Cite
MLA Citation
Meghali Goswami et al.. “Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia.” Journal for immunotherapy of cancer, vol. 10, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100148213428.0x000014